Literature DB >> 19260953

The bone marker plot: an innovative method to assess bone turnover in women.

C Bieglmayer1, S Kudlacek.   

Abstract

BACKGROUND: Biochemical markers of bone turnover reflect the resorptive and reconstructive effects that act on the skeleton. Although elevated markers are commonly interpreted as a sign of an increased turnover rate, the balance between bone resorption and formation is mostly neglected. We introduce a graphic report combining both complementary processes.
MATERIALS AND METHODS: Bone turnover markers were measured in 599 women (aged 25-74 years). To set up reference ranges, 269 from 599 women were selected because of having T-scores > -1 and inconspicuous basic laboratory data. Concentrations of resorption and formation markers were mathematically transformed to build up plots with four fields, symbolizing fast and slow resorption and fast and slow formation processes. The reference data of bone turnover were represented by a 95% confidence ellipse. For individual marker plots, we converted data of bone turnover markers from therapy follow-up profiles of patients in a similar manner.
RESULTS: In pre-, peri- and postmenopausal women (n= 190, 39 +/- 6 years; n= 35, 51 +/- 6 years; n= 44, 55 +/- 5 years, respectively), the medians of the bone resorption marker CrossLaps and of the bone formation markers osteocalcin and aminoterminal propeptide of type I procollagen were 0.13/0.16/0.22 ng mL(-1), 21/21/25 ng mL(-1) and 36/35/45 ng mL(-1), respectively. In postmenopausal women, the marker plots revealed a shift towards accelerated bone resorption. A discrimination from osteopenic women (n= 138) failed.
CONCLUSION: The proposed marker plot facilitates the intuitive perception of bone turnover in individual patients as well as in patient groups by a synopsis of the balance between bone formation and resorption with the rate of these processes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19260953     DOI: 10.1111/j.1365-2362.2009.02087.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  10 in total

1.  Bone remodeling markers: so easy to measure, so difficult to interpret.

Authors:  E Seeman; T V Nguyen
Journal:  Osteoporos Int       Date:  2015-11-11       Impact factor: 4.507

2.  The importance of assessing the rate of bone turnover and the balance between bone formation and bone resorption during daily teriparatide administration for osteoporosis: a pilot study.

Authors:  Shinichi Nakatoh
Journal:  J Bone Miner Metab       Date:  2015-06-02       Impact factor: 2.626

3.  Radon balneotherapy and physical activity for osteoporosis prevention: a randomized, placebo-controlled intervention study.

Authors:  Martina Winklmayr; Christian Kluge; Wolfgang Winklmayr; Helmut Küchenhoff; Martina Steiner; Markus Ritter; Arnulf Hartl
Journal:  Radiat Environ Biophys       Date:  2014-10-02       Impact factor: 1.925

4.  Effect of osteoporosis medication on changes in bone mineral density and bone turnover markers after 24-month administration of daily teriparatide: comparison among minodronate, raloxifene, and eldecalcitol.

Authors:  Shinichi Nakatoh
Journal:  J Bone Miner Metab       Date:  2017-03-14       Impact factor: 2.626

5.  Quantifying the Balance Between Total Bone Formation and Total Bone Resorption: An Index of Net Bone Formation.

Authors:  Albert Shieh; Weijuan Han; Shinya Ishii; Gail A Greendale; Carolyn J Crandall; Arun S Karlamangla
Journal:  J Clin Endocrinol Metab       Date:  2016-06-23       Impact factor: 5.958

6.  Effect of isolated vitamin D supplementation on bone turnover markers in younger postmenopausal women: a randomized, double-blind, placebo-controlled trial.

Authors:  J Nahas-Neto; L M Cangussu; C L Orsatti; F N Bueloni-Dias; P F Poloni; E B Schmitt; E A P Nahas
Journal:  Osteoporos Int       Date:  2018-02-15       Impact factor: 4.507

7.  Bone Turnover Status: Classification Model and Clinical Implications.

Authors:  Alexander Fisher; Leon Fisher; Wichat Srikusalanukul; Paul N Smith
Journal:  Int J Med Sci       Date:  2018-02-01       Impact factor: 3.738

8.  Bone turnover rate and bone formation/resorption balance during the early stage after switching from a bone resorption inhibitor to denosumab are predictive factors of bone mineral density change.

Authors:  Shinichi Nakatoh
Journal:  Osteoporos Sarcopenia       Date:  2017-01-17

Review 9.  The clinical utility of bone marker measurements in osteoporosis.

Authors:  Gillian Wheater; Mohsen Elshahaly; Stephen P Tuck; Harish K Datta; Jacob M van Laar
Journal:  J Transl Med       Date:  2013-08-29       Impact factor: 5.531

10.  Effects of post exercise protein supplementation on markers of bone turnover in adolescent swimmers.

Authors:  Alexandros Theocharidis; Brandon J McKinlay; Dimitris Vlachopoulos; Andrea R Josse; Bareket Falk; Panagiota Klentrou
Journal:  J Int Soc Sports Nutr       Date:  2020-04-15       Impact factor: 5.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.